Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Logos Global Management LP
Form 13F · Q2 2026

Logos Global Management LP

CIK 1792126申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$23.2亿
申报组合市值
68
持仓数量
12
Quarters on record
Top 50
持仓数量

Logos Global Management LP——持仓

共 68 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1ERAS Erasca Inc12.2M+9.0%$2.2亿9.6%
2ABVX Abivax Sa1.0M+51.7%$1.4亿5.9%
3RVMD Revolution Medicines Inc700,000−65.0%$1.3亿5.6%
4IDYA Ideaya Biosciences Inc3.0M−13.0%$1.1亿4.8%
5BNTX Biontech Se1.0M—$9445万4.1%
6VERA Vera Therapeutics Inc2.2M—$9440万4.1%
7TNGX Tango Therapeutics Inc2.9M−5.0%$8909万3.8%
8PRAX Praxis Precision Medicines I260,000−8.8%$8705万3.7%
9CLDX Celldex Therapeutics Inc New2.1M+366.7%$7814万3.4%
10DNTH Dianthus Therapeutics Inc800,000+100.0%$7798万3.4%
11CGON Cg Oncology Inc1.0M+73.9%$7105万3.1%
12IRON Disc Medicine Inc875,000+56.2%$6400万2.8%
13MAZE Maze Therapeutics Inc1.9M+56.7%$5774万2.5%
14DYN Dyne Therapeutics Inc2.5M+82.1%$5664万2.4%
15MLTX Moonlake Immunotherapeutics2.7M+78.3%$5208万2.2%
16OCUL Ocular Therapeutix Inc5.3M+37.7%$5205万2.2%
17DSGN Design Therapeutics Inc3.0M+53.8%$4341万1.9%
18OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc3.2M+0.0%$4014万1.7%
19BLTE Belite Bio Inc250,000—$3850万1.7%
20QUIT Achieve Life Science Inc5.4M—$3543万1.5%
21TRVI Trevi Therapeutics Inc1.9M−21.7%$3506万1.5%
22COGT Cogent Biosciences Inc900,000—$3483万1.5%
23AVBP Arrivent Biopharma Inc1.0M+185.7%$3474万1.5%
24CBIO Crescent Biopharma Inc.1.9M+293.8%$3420万1.5%
25CMPS Compass Pathways Plc2.2M—$3184万1.4%
26MLYS Mineralys Therapeutics Inc1.1M—$2833万1.2%
27REPL Replimune Group Inc2.5M—$2768万1.2%
28XENE Xenon Pharmaceuticals Inc450,000+0.0%$2716万1.2%
29GPCR Structure Therapeutics Inc500,000+0.0%$2684万1.2%
30IMVT Immunovant Inc665,000−38.1%$2562万1.1%
31JBIO Jade Biosciences Inc1.1M+181.2%$2500万1.1%
32ELVN Enliven Therapeutics Inc465,000−13.9%$2360万1.0%
33MANE Veradermics Inc180,000+620.0%$2213万1.0%
34AVTX Avalo Therapeutics Inc1.1M+283.3%$2125万0.9%
35RCUS Arcus Biosciences Inc650,000−45.8%$2004万0.9%
36SMMT Summit Therapeutics Inc1.4M—$1967万0.8%
37IMCR Immunocore Hldgs Plc600,000−60.0%$1905万0.8%
38LBRX Lb Pharmaceuticals Inc585,000−36.1%$1899万0.8%
39NERV Minerva Neurosciences Inc3.3M+2.3%$1825万0.8%
40FTH Faeth Therapeutics Inc722,020+2306.7%$1805万0.8%
41CRSP Crispr Therapeutics Ag300,000—$1636万0.7%
42DBVT Dbv Technologies S A915,000—$1501万0.6%
43PBLS Parabilis Medicines Inc525,000—$1437万0.6%
44RYTM Rhythm Pharmaceuticals Inc125,000−72.2%$1388万0.6%
45VOR Vor Biopharma Inc650,000−13.3%$1197万0.5%
46SRRK Scholar Rock Hldg Corp200,000—$1100万0.5%
47IMMX Immix Biopharma Inc1.0M−18.4%$1031万0.4%
48QTTB Q32 Bio Inc800,000—$1019万0.4%
49ODTX Odyssey Therapeutics Inc521,736—$976万0.4%
50ANNX Annexon Inc1.5M—$856万0.4%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。